Compared with the DU145-RCC2 group, the tumor size and tumor volume in the DU145-RCC2 + GANT61 group were significantly decreased, indicating that inhibiting Gli1 reversed the effect of RCC on tumor growth. Here, GLI1 is linked to neoplasm.